Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease

Parkinson's disease (PD), one of the most common movement and neurodegenerative disorders, is challenging to treat, largely because the blood-brain barrier blocks passage of most drugs. Here we find exosomes from blood showing natural brain targeting ability which involved the transferrin-trans...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2018-10, Vol.287, p.156-166
Main Authors: Qu, Mengke, Lin, Qing, Huang, Luyi, Fu, Yao, Wang, Luyao, He, Shanshan, Fu, Yu, Yang, Shengyong, Zhang, Zhirong, Zhang, Ling, Sun, Xun
Format: Article
Language:English
Subjects:
Blood exosomes
Brain targeting
Drug delivery
Mechanism of targeting
Parkinson's disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parkinson's disease (PD), one of the most common movement and neurodegenerative disorders, is challenging to treat, largely because the blood-brain barrier blocks passage of most drugs. Here we find exosomes from blood showing natural brain targeting ability which involved the transferrin-transferrin receptor interaction. Thus, we develop a biocompatible platform based on blood exosomes for delivering drugs across the blood-brain barrier. Blood exosomes show sizes between 40 and 200 nm and spherical morphology, and dopamine can be efficiently loaded into blood exosomes by a saturated solution incubation method. Further in vitro and in vivo studies demonstrates these exosomes successfully delivered dopamine to brain, including the striatum and substantia nigra. Brain distribution of dopamine increased >15-fold by using the blood exosomes as delivery system. Dopamine-loaded exosomes show much better therapeutic efficacy in a PD mouse model and lower systemic toxicity than free dopamine after intravenous administration. These results suggest that blood exosomes can be used as a promising drug delivery platform for targeted therapy against PD and other diseases of the central nervous system. [Display omitted] •Blood exosomes released by reticulocytes have natural brain targeting ability.•The targeting mechanism involves the transferrin-transferrin receptor interaction.•Crude blood exosomes can serve as drug carriers for brain targeted drug delivery.•Dopamine-loaded blood exosomes improve the treatment of Parkinson's disease.
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2018.08.035